• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于估算带有标记代谢物的示踪剂血-组织转移常数的图形分析方法。

A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites.

作者信息

Mankoff D A, Shields A F, Graham M M, Link J M, Krohn K A

机构信息

Division of Nuclear Medicine, University of Washington, Seattle, USA.

出版信息

J Nucl Med. 1996 Dec;37(12):2049-57.

PMID:8970533
Abstract

UNLABELLED

The Patlak graphical analysis technique is a popular tool for estimating blood-to-tissue transfer constants from multiple-time uptake data. Our objective was to extend this technique to tracers with labeled metabolites, the presence of which can cause errors in the standard Patlak analysis.

METHODS

Based on previously described formulations, we generalized the graphical technique for use under specific conditions. To test the extended graphical approach, we applied the method to both simulated and patient data using a preliminary compartmental model for the PET tumor proliferation marker, 2-[11C]-thymidine.

RESULTS

When given conditions are met, a linear relationship exists between the normalized tissue activity (tissue activity/blood activity) and a new set of graphical analysis basis functions, including a new definition of normalized time, which takes the presence of labeled metabolites into account. Graphical estimations of the tumor thymidine incorporation rate for simulated data were accurate and showed close agreement to the results of detailed compartmental analysis. In patient studies, the graphical and compartmental estimates showed good agreement but a somewhat poorer correlation than in the simulations.

CONCLUSION

The extended graphical analysis approach provides an efficient method for estimating blood-tissue transfer constants for tracers with labeled metabolites.

摘要

未标注

Patlak图形分析技术是一种用于从多次摄取数据估算血-组织转运常数的常用工具。我们的目标是将该技术扩展到含有标记代谢物的示踪剂,标记代谢物的存在会导致标准Patlak分析出现误差。

方法

基于先前描述的公式,我们将图形技术推广到特定条件下使用。为了测试扩展后的图形方法,我们使用PET肿瘤增殖标志物2-[11C]-胸腺嘧啶核苷的初步房室模型,将该方法应用于模拟数据和患者数据。

结果

在满足给定条件时,归一化组织活性(组织活性/血液活性)与一组新的图形分析基函数之间存在线性关系,包括考虑了标记代谢物存在的归一化时间的新定义。模拟数据的肿瘤胸腺嘧啶核苷掺入率的图形估计是准确的,并且与详细房室分析的结果显示出密切的一致性。在患者研究中,图形估计和房室估计显示出良好的一致性,但相关性略逊于模拟研究。

结论

扩展后的图形分析方法为估算含有标记代谢物的示踪剂的血-组织转运常数提供了一种有效的方法。

相似文献

1
A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites.一种用于估算带有标记代谢物的示踪剂血-组织转移常数的图形分析方法。
J Nucl Med. 1996 Dec;37(12):2049-57.
2
Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis.2-[碳-11]胸腺嘧啶正电子发射断层显像(PET)成像研究的动力学分析:房室模型与数学分析
J Nucl Med. 1998 Jun;39(6):1043-55.
3
A strategy for removing the bias in the graphical analysis method.一种消除图形分析方法中偏差的策略。
J Cereb Blood Flow Metab. 2001 Mar;21(3):307-20. doi: 10.1097/00004647-200103000-00014.
4
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies.
J Nucl Med. 1999 Apr;40(4):614-24.
5
Quantitative analysis of 11C-verapamil transfer at the human blood-brain barrier for evaluation of P-glycoprotein function.用于评估P-糖蛋白功能的人血脑屏障处¹¹C-维拉帕米转运的定量分析。
J Nucl Med. 2006 Sep;47(9):1531-7.
6
In vivo distribution and identification of 11C-activity after injection of [methyl-11C]thymidine in Wistar rats.在Wistar大鼠中注射[甲基 - 11C]胸苷后11C活性的体内分布与鉴定
J Nucl Med. 1999 Mar;40(3):491-6.
7
Physiologic smoothing of blood time-activity curves for PET data analysis.用于PET数据分析的血液时间-活度曲线的生理平滑处理。
J Nucl Med. 1997 Jul;38(7):1161-8.
8
Graphical analysis of PET data applied to reversible and irreversible tracers.应用于可逆和不可逆示踪剂的PET数据的图形分析。
Nucl Med Biol. 2000 Oct;27(7):661-70. doi: 10.1016/s0969-8051(00)00137-2.
9
Pharmacokinetics of radiotracers in human plasma during positron emission tomography.
Synapse. 1999 Nov;34(2):124-34. doi: 10.1002/(SICI)1098-2396(199911)34:2<124::AID-SYN5>3.0.CO;2-O.
10
A general method to correct PET data for tissue metabolites using a dual-scan approach.
J Nucl Med. 2000 Apr;41(4):706-11.

引用本文的文献

1
Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds.碳-11 标记的内源性和天然外源性化合物的放射性合成、临床前和临床正电子发射断层扫描研究。
Chem Rev. 2023 Jan 11;123(1):105-229. doi: 10.1021/acs.chemrev.2c00398. Epub 2022 Nov 18.
2
Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology.肿瘤示踪动力学分析原理,第一部分:原理与方法概述。
J Nucl Med. 2022 Mar;63(3):342-352. doi: 10.2967/jnumed.121.263518.
3
Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics.
放射性标记胆碱动力学中代谢物外排的考量
Pharmaceutics. 2021 Aug 12;13(8):1246. doi: 10.3390/pharmaceutics13081246.
4
Introduction to the analysis of PET data in oncology.肿瘤学中 PET 数据的分析简介。
J Pharmacokinet Pharmacodyn. 2013 Aug;40(4):419-36. doi: 10.1007/s10928-013-9307-3. Epub 2013 Feb 27.
5
Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data.评估有限血样人群输入方法在[18F]氟脱氧胸苷 PET 数据动力学定量中的应用。
EJNMMI Res. 2012 Mar 24;2:11. doi: 10.1186/2191-219X-2-11.
6
Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.肿瘤 PET 数据分析中定量的重要性:当前方法综述及未来趋势。
Mol Imaging Biol. 2012 Apr;14(2):131-46. doi: 10.1007/s11307-011-0514-2.
7
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.美国国立癌症研究所赞助的一项试验,旨在评估3'-脱氧-3'-[18F]氟胸苷(FLT)作为复发性神经胶质瘤患者增殖标志物的安全性和初步疗效:初步疗效研究。
Mol Imaging Biol. 2009 Sep-Oct;11(5):343-55. doi: 10.1007/s11307-009-0215-2. Epub 2009 Mar 27.
8
The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.靶向治疗时代DNA合成成像在癌症中的作用。
Cancer Metastasis Rev. 2008 Dec;27(4):575-87. doi: 10.1007/s10555-008-9148-5.
9
Targeted molecular imaging in oncology: focus on radiation therapy.肿瘤学中的靶向分子成像:聚焦于放射治疗。
Semin Radiat Oncol. 2008 Apr;18(2):136-48. doi: 10.1016/j.semradonc.2007.10.009.
10
Use of positron emission tomography in anticancer drug development.
Invest New Drugs. 2003 May;21(2):169-81. doi: 10.1023/a:1023521412787.